Please use this identifier to cite or link to this item: http://repositorio.unifesp.br/handle/11600/30362
Title: Phosphate Binder Impact on Bone Remodeling and Coronary Calcification - Results from the BRiC Study
Authors: Barreto, Daniela Veit [UNIFESP]
Barreto, Fellype de Carvalho [UNIFESP]
Carvalho, Aluizio Barbosa de [UNIFESP]
Cuppari, Lilian [UNIFESP]
Draibe, Sergio Antonio [UNIFESP]
Dalboni, Maria Aparecida [UNIFESP]
Affonso Moyses, Rosa Maria
Neves, Katia Rodrigues
Jorgetti, Vanda
Miname, Marcio
Santos, Raul D.
Fernandes Canziani, Maria Eugenia [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
Keywords: Cardiovascular disease
Hemodialysis
Phosphate binders
Renal osteodystrophy
Vascular calcification
Issue Date: 1-Jan-2008
Publisher: Karger
Citation: Nephron Clinical Practice. Basel: Karger, v. 110, n. 4, p. C273-C283, 2008.
Abstract: Background and Aims: Calcium-containing phosphate binders have been shown to increase the progression of vascular calcification in hemodialysis patients. This is a prospective study that compares the effects of calcium acetate and sevelamer on coronary calcification (CAC) and bone histology. Methods: 101 hemodialysis patients were randomized for each phosphate binder and submitted to multislice coronary tomographies and bone biopsies at entry and 12 months. Results: the 71 patients who concluded the study had similar baseline characteristics. On follow-up, the sevelamer group had higher levels of intact parathyroid hormone (498 +/- 352 vs. 326 +/- 236 pg/ml, p = 0.017), bone alkaline phosphatase (38 +/- 24 vs. 28 +/- 15 U/l, p = 0.03) and deoxypyridinoline (135 +/- 107 vs. 89 +/- 71 nmol/l, p = 0.03) and lower LDL cholesterol (74 +/- 21 vs. 91 +/- 28 mg/dl, p = 0.015). Phosphorus (5.8 +/- 1.0 vs. 6 +/- 1.0 mg/dl, p = 0.47) and calcium (1.27 +/- 0.07 vs. 1.23 +/- 0.08 mmol/l, p = 0.68) levels did not differ between groups. CAC progression (35 vs. 24%, p = 0.94) and bone histological diagnosis at baseline and 12 months were similar in both groups. Patients of the sevelamer group with a high turnover at baseline had an increase in bone resorption (eroded surface, ES/BS = 9.0 +/- 5.9 vs. 13.1 +/- 9.5%, p = 0.05), whereas patients of both groups with low turnover at baseline had an improvement in bone formation rate (BFR/BS = 0.015 +/- 0.016 vs. 0.062 +/- 0.078, p = 0.003 for calcium and 0.017 +/- 0.016 vs. 0.071 +/- 0.084 mu m(3)/mu m(2)/day, p = 0.010 for sevelamer). Conclusions: There was no difference in CAC progression or changes in bone remodeling between the calcium and the sevelamer groups. Copyright (C) 2008 S. Karger AG, Basel
URI: http://repositorio.unifesp.br/handle/11600/30362
ISSN: 1660-2110
Other Identifiers: http://dx.doi.org/10.1159/000170783
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.